QRXPY Financials 07/15/2014 23:56:02 QRxPharma Li

QRXPY Financials 07/15/2014 23:56:02
QRxPharma Limited
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 3,722 1,967 189 220
Cost of Revenue - - - -
Gross Profit 3,722 1,967 189 220
Operating Expenses
Research and Development 7,561 9,392 16,068 15,209
Sales, General and Admin. 6,013 11,278 10,059 8,104
Non-Recurring Items - - - -
Other 59 67 71 55
Operating Income (9,911) (18,770) (26,008) (23,148)
Income From Continuing Operations
Add'l Income/Expense Items 684 2,323 (1,437) (58)
Earnings Before Interest and Tax (9,227) (16,447) (27,445) (23,206)
Interest Expense - - - -
Earnings Before Tax (9,227) (16,447) (27,445) (23,206)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (9,227) (16,447) (27,445) (23,206)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (9,227) (16,447) (27,445) (23,206)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (9,227) (16,447) (27,445) (23,206)